French President Emmanuel Macron on May 13, 2024 (Thibault Camus/AP Images, Pool)
May 13, 2024 05:11 AM EDTUpdated 11:26 AM
Financing
Manufacturing

Up­dat­ed: France draws €2B+ re­search, man­u­fac­tur­ing in­vest­ment from Sanofi, Pfiz­er, As­traZeneca, GSK

Amber Tong

Reynald Castañeda

Deputy Editor

Anna Brown

News Reporter

Sanofi, Pfiz­er and As­traZeneca sep­a­rate­ly pledged to in­crease their foot­print in France, with in­vest­ments adding up to al­most €2 bil­lion. GSK, Ab­b­Vie and No­var­tis are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Chi­nese drug­mak­er re­ceives FDA warn­ing let­ter af­ter man­age­ment hin­dered in­spec­tion

GSK plots reg­u­la­to­ry fil­ings for PBC itch af­ter pos­i­tive Phase 3 read­out

J&J, Pro­tag­o­nist re­veal two Phase 3 wins for oral IL-23 drug that's ex­pect­ed to be a block­buster

Bio­gen, UCB de­tail re­sponse rates in Phase 3 lu­pus tri­al af­ter sur­pris­ing suc­cess

Mer­ck fi­nal­ly has sub­cu­ta­neous Keytru­da re­sults, and it's go­ing to reg­u­la­tors

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times